Insights
Insights From Our Experts
Articles
Report: Integrated Delivery Network Trends and Engagement Strategies Every Drug Manufacturer Needs to Know
Unlock the full potential of your Integrated Delivery Network (IDN) strategies with EVERSANA’s latest Market Research & Insights Report. Drug manufacturers are engaging with IDNs to address pain points and trends, optimize patient outcomes, and foster…
European Parliament’s Revision of the General Pharmaceutical Legislation
The European Parliament has adopted a revision of the general pharmaceutical legislation, repealing and amending previous legislation with a set of compromise amendments. According to the European Commission, it has been called “the largest reform in…
Market Access and the Inflation Reduction Act
The Inflation Reduction Act of 2022 (IRA) institutes Medicare changes that include the ability to negotiate drug prices, limit price increases and cap out-of-pocket costs for beneficiaries. Understanding the far-reaching implications of these provisions is crucial…
Optimizing Product Commercialization in Today’s IDN Environment
The healthcare landscape is undergoing a significant transformation with the rise of Integrated Delivery Networks (IDNs), now employing nearly 70% of U.S. physicians. As IDNs become more prevalent, they bring numerous advantages, such as enhanced physician…
Navigating the PBAC: Strategies for Successful Reimbursement Applications
Authors: Ravi Visweswara, Executive Vice President, EVERSANA APAC; Robin Arnold, Executive Vice President, EVERSANA APAC; Amish Chaturvedi, Senior Director, Pricing and Market Access, EVERSANA APAC; Paul Lindsay, Senior Director, Pricing and Market Access, EVERSANA Australia Crafting…
Navigating the Evolution of Precision Medicine: Data-Driven Strategies for Life Sciences Commercialization
The landscape of pharmaceutical commercialization has undergone a remarkable transformation over the past decade. Traditional blockbuster drugs, once the hallmark of the industry, have given way to other products such as targeted therapeutics designed for rare…
Optimizing Patient-Centered Care: Strategies for Improving Health Outcomes
With a rapidly evolving health insurance landscape in India, it is imperative to understand the challenges and potential solutions for innovative medical technologies reimbursement by private health insurance in India. EVERSANA recently partnered with St. Jude…
Bridging “Share of Voice” with “Share of Influence” for Lasting Impact
In today’s complex healthcare environment, manufacturers must navigate an evolving stakeholder landscape to guarantee patient access and successful product launches. This article explores how deploying a strategic approach that establishes a “share of influence” across the…
Integrated Delivery Networks (IDNs): Driving Change in Drug Access and Utilization
As of May 2024, a striking 77.6% of physicians in the United States are employed by hospitals, health systems and corporate entities – a significant surge from less than 50% a mere decade ago. This trend…
Excel in Market Access Success: Key Considerations for Leveraging Your Evidence
Introduction The landscape of launching new medical products presents significant challenges, with a staggering 66% of launches falling short of consensus expectations. Half of these failures are attributed directly to poor market access. Recognizing this, companies…